 | • レポートコード：MRC2012A0554 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗真菌薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗真菌薬の種類別市場規模（アゾール、エキノカンジン、ポリエン、アリルアミン、その他）、用途別市場規模（皮膚糸状菌症、アスペルギルス症、カンジダ症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、GlaxoSmithKline、Merck、Pfizer、Astellas Pharma、Sanofi、J & J、Bayer、Enzon Pharmaceuticals、Abbott、Teva、Mylan、 ・地域別グローバル市場分析 2015年-2020年 ・抗真菌薬の北米市場（アメリカ、カナダ、メキシコ） ・抗真菌薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗真菌薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗真菌薬の南米市場（ブラジル、アルゼンチン） ・抗真菌薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アゾール、エキノカンジン、ポリエン、アリルアミン、その他 ・用途別分析：皮膚糸状菌症、アスペルギルス症、カンジダ症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Antifungal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 14750 million by 2025, from USD 13170 million in 2019.
The Antifungal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antifungal Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antifungal Drugs market has been segmented into
Azoles
Echinocandins
Polyenes
Allylamines
Others
By Application, Antifungal Drugs has been segmented into:
Dermatophytosis
Aspergillosis
Candidiasis
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antifungal Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Antifungal Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antifungal Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Antifungal Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Antifungal Drugs Market Share Analysis
Antifungal Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antifungal Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antifungal Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Antifungal Drugs are:
Novartis
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Sanofi
J & J
Bayer
Enzon Pharmaceuticals
Abbott
Teva
Mylan
Among other players domestic and global, Antifungal Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antifungal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antifungal Drugs, with price, sales, revenue and global market share of Antifungal Drugs in 2018 and 2019.
Chapter 3, the Antifungal Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antifungal Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antifungal Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antifungal Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antifungal Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antifungal Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Azoles
1.2.3 Echinocandins
1.2.4 Polyenes
1.2.5 Allylamines
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Antifungal Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dermatophytosis
1.3.3 Aspergillosis
1.3.4 Candidiasis
1.3.5 Others
1.4 Overview of Global Antifungal Drugs Market
1.4.1 Global Antifungal Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Astellas Pharma SWOT Analysis
2.5.4 Astellas Pharma Product and Services
2.5.5 Astellas Pharma Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 J & J
2.7.1 J & J Details
2.7.2 J & J Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 J & J SWOT Analysis
2.7.4 J & J Product and Services
2.7.5 J & J Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Enzon Pharmaceuticals
2.9.1 Enzon Pharmaceuticals Details
2.9.2 Enzon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Enzon Pharmaceuticals SWOT Analysis
2.9.4 Enzon Pharmaceuticals Product and Services
2.9.5 Enzon Pharmaceuticals Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott SWOT Analysis
2.10.4 Abbott Product and Services
2.10.5 Abbott Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva
2.11.1 Teva Details
2.11.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva SWOT Analysis
2.11.4 Teva Product and Services
2.11.5 Teva Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mylan
2.12.1 Mylan Details
2.12.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Mylan SWOT Analysis
2.12.4 Mylan Product and Services
2.12.5 Mylan Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antifungal Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antifungal Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antifungal Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Antifungal Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antifungal Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antifungal Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antifungal Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Antifungal Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Antifungal Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antifungal Drugs Sales and Growth Rate (2015-2020)
4.5 South America Antifungal Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antifungal Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antifungal Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Antifungal Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Antifungal Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Antifungal Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Antifungal Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Antifungal Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antifungal Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Antifungal Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antifungal Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Antifungal Drugs Sales and Growth Rate (2015-2020)
6.3 UK Antifungal Drugs Sales and Growth Rate (2015-2020)
6.4 France Antifungal Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Antifungal Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Antifungal Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antifungal Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antifungal Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antifungal Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Antifungal Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Antifungal Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Antifungal Drugs Sales and Growth Rate (2015-2020)
7.5 India Antifungal Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antifungal Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Antifungal Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antifungal Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Antifungal Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Antifungal Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antifungal Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Antifungal Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antifungal Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antifungal Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antifungal Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antifungal Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Antifungal Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Antifungal Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Antifungal Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antifungal Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Antifungal Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Antifungal Drugs Price by Type (2015-2020)
11 Global Antifungal Drugs Market Segment by Application
11.1 Global Antifungal Drugs Sales Market Share by Application (2015-2020)
11.2 Global Antifungal Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Antifungal Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antifungal Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Antifungal Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Antifungal Drugs Market Forecast (2021-2025)
12.2.2 Europe Antifungal Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antifungal Drugs Market Forecast (2021-2025)
12.2.4 South America Antifungal Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antifungal Drugs Market Forecast (2021-2025)
12.3 Antifungal Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Antifungal Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Antifungal Drugs Market Share Forecast by Type (2021-2025)
12.4 Antifungal Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Antifungal Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Antifungal Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Antifungal Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antifungal Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antifungal Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Antifungal Drugs Major Business
Table 9. Novartis Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Antifungal Drugs Product and Services
Table 12. Novartis Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Antifungal Drugs Major Business
Table 15. GlaxoSmithKline Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 16. GlaxoSmithKline SWOT Analysis
Table 17. GlaxoSmithKline Antifungal Drugs Product and Services
Table 18. GlaxoSmithKline Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Antifungal Drugs Major Business
Table 21. Merck Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Antifungal Drugs Product and Services
Table 24. Merck Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Antifungal Drugs Major Business
Table 27. Pfizer Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Antifungal Drugs Product and Services
Table 30. Pfizer Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Astellas Pharma Antifungal Drugs Major Business
Table 33. Astellas Pharma Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Astellas Pharma SWOT Analysis
Table 35. Astellas Pharma Antifungal Drugs Product and Services
Table 36. Astellas Pharma Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi Antifungal Drugs Major Business
Table 39. Sanofi Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Sanofi SWOT Analysis
Table 41. Sanofi Antifungal Drugs Product and Services
Table 42. Sanofi Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. J & J Basic Information, Manufacturing Base and Competitors
Table 44. J & J Antifungal Drugs Major Business
Table 45. J & J Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 46. J & J SWOT Analysis
Table 47. J & J Antifungal Drugs Product and Services
Table 48. J & J Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bayer Basic Information, Manufacturing Base and Competitors
Table 50. Bayer Antifungal Drugs Major Business
Table 51. Bayer Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Bayer SWOT Analysis
Table 53. Bayer Antifungal Drugs Product and Services
Table 54. Bayer Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Enzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Enzon Pharmaceuticals Antifungal Drugs Major Business
Table 57. Enzon Pharmaceuticals Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Enzon Pharmaceuticals SWOT Analysis
Table 59. Enzon Pharmaceuticals Antifungal Drugs Product and Services
Table 60. Enzon Pharmaceuticals Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Abbott Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Antifungal Drugs Major Business
Table 63. Abbott Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Abbott SWOT Analysis
Table 65. Abbott Antifungal Drugs Product and Services
Table 66. Abbott Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Basic Information, Manufacturing Base and Competitors
Table 68. Teva Antifungal Drugs Major Business
Table 69. Teva Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Teva SWOT Analysis
Table 71. Teva Antifungal Drugs Product and Services
Table 72. Teva Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Mylan Basic Information, Manufacturing Base and Competitors
Table 74. Mylan Antifungal Drugs Major Business
Table 75. Mylan Antifungal Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Mylan SWOT Analysis
Table 77. Mylan Antifungal Drugs Product and Services
Table 78. Mylan Antifungal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Antifungal Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Antifungal Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Antifungal Drugs Sales by Regions (2015-2020) (K Units)
Table 82. Global Antifungal Drugs Sales Market Share by Regions (2015-2020)
Table 83. Global Antifungal Drugs Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Antifungal Drugs Sales by Countries (2015-2020) (K Units)
Table 85. North America Antifungal Drugs Sales Market Share by Countries (2015-2020)
Table 86. North America Antifungal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Antifungal Drugs Revenue Market Share by Countries (2015-2020)
Table 88. Europe Antifungal Drugs Sales by Countries (2015-2020) (K Units)
Table 89. Europe Antifungal Drugs Sales Market Share by Countries (2015-2020)
Table 90. Europe Antifungal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Antifungal Drugs Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Antifungal Drugs Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Antifungal Drugs Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Antifungal Drugs Sales by Countries (2015-2020) (K Units)
Table 95. South America Antifungal Drugs Sales Market Share by Countries (2015-2020)
Table 96. South America Antifungal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Antifungal Drugs Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Antifungal Drugs Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Antifungal Drugs Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Antifungal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Antifungal Drugs Revenue Market Share by Countries (2015-2020)
Table 102. Global Antifungal Drugs Sales by Type (2015-2020) (K Units)
Table 103. Global Antifungal Drugs Sales Share by Type (2015-2020)
Table 104. Global Antifungal Drugs Revenue by Type (2015-2020) (USD Million)
Table 105. Global Antifungal Drugs Revenue Share by Type (2015-2020)
Table 106. Global Antifungal Drugs Sales by Application (2015-2020) (K Units)
Table 107. Global Antifungal Drugs Sales Share by Application (2015-2020)
Table 108. Global Antifungal Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Antifungal Drugs Market Share Forecast by Regions (2021-2025)
Table 110. Global Antifungal Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Antifungal Drugs Market Share Forecast by Type (2021-2025)
Table 112. Global Antifungal Drugs Sales Forecast by Application (2021-2025)
Table 113. Global Antifungal Drugs Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antifungal Drugs Picture
Figure 2. Global Sales Market Share of Antifungal Drugs by Type in 2019
Figure 3. Azoles Picture
Figure 4. Echinocandins Picture
Figure 5. Polyenes Picture
Figure 6. Allylamines Picture
Figure 7. Others Picture
Figure 8. Antifungal Drugs Sales Market Share by Application in 2018
Figure 9. Dermatophytosis Picture
Figure 10. Aspergillosis Picture
Figure 11. Candidiasis Picture
Figure 12. Others Picture
Figure 13. Global Antifungal Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Antifungal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Antifungal Drugs Sales Market Share by Manufacturer in 2019
Figure 34. Global Antifungal Drugs Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Antifungal Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Antifungal Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Antifungal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Antifungal Drugs Revenue Market Share by Regions (2015-2020)
Figure 41. Global Antifungal Drugs Revenue Market Share by Regions in 2018
Figure 42. North America Antifungal Drugs Sales and Growth Rate (2015-2020)
Figure 43. Europe Antifungal Drugs Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Antifungal Drugs Sales and Growth Rate (2015-2020)
Figure 45. South America Antifungal Drugs Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Antifungal Drugs Sales and Growth Rate (2015-2020)
Figure 47. North America Antifungal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Antifungal Drugs Sales Market Share by Countries (2015-2020)
Figure 49. North America Antifungal Drugs Sales Market Share by Countries in 2018
Figure 50. North America Antifungal Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Antifungal Drugs Revenue Market Share by Countries in 2018
Figure 52. United States Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Antifungal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Antifungal Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Antifungal Drugs Revenue Market Share by Countries in 2019
Figure 58. Germany Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Antifungal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Antifungal Drugs Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Antifungal Drugs Revenue Market Share by Regions 2019
Figure 66. China Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Antifungal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Antifungal Drugs Sales Market Share by Countries in 2019
Figure 73. South America Antifungal Drugs Revenue Market Share by Countries in 2019
Figure 74. Brazil Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Antifungal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Antifungal Drugs Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Antifungal Drugs Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Antifungal Drugs Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Antifungal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Antifungal Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Antifungal Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Antifungal Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Antifungal Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Antifungal Drugs Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Antifungal Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Antifungal Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
抗真菌薬の世界市場（～2026年） Novartis AG (Switzerland), Pfizer Inc. (U.S), Sanofi (France), Merck & Co., Inc. (U.S), Astellas (Japan), Bayer AG (Germany) Increasing prevalence of HIV in Asia Pacific region is the key factor for the market growth. Rising awareness about the antifungal treatment and availability of new treatment …- 工業用抗真菌剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Industrial Antifungal Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- アスペルギルス症薬の世界市場（～2026年） Market Analysis and Insights: Global Aspergillosis Drugs Market The global Aspergillosis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Aspergillosis Drugs Scope and Market Size Aspergillosis Drugs market is seg…
- 院内肺炎（HAP）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hospital-acquired Pneumonia (HAP) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospi…
- 院内肺炎（HAP）治療薬の世界市場（～2026年） HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects …